Human group III phospholipase A2 suppresses adenovirus infection into host cells. Evidence that group III, V and X phospholipase A2s act on distinct cellular phospholipid molecular species

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1771, Issue 11, 2007, Pages 1389-1396

  Mitsuishi, Michiko ^a   Masuda, Seiko ^a,b   Kudo, Ichiro ^a   Murakami, Makoto ^a,b,c  

^a SHOWA UNIVERSITY   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Adenovirus; Lysophosphatidylcholine; Mass spectrometry; Phosphatidylethanolamine; Phospholipase A2; Plasma membrane

Indexed keywords

BEE VENOM; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; PHOSPHOLIPID;

ADENOVIRUS; AMINO TERMINAL SEQUENCE; ARTICLE; BRONCHUS MUCOSA; CARBOXY TERMINAL SEQUENCE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVE SITE; HOST CELL; HUMAN; HUMAN CELL; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN LIPID INTERACTION; VIRUS CELL INTERACTION; VIRUS INFECTION;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; CELL LINE; CELL MEMBRANE; GROUP III PHOSPHOLIPASES A2; GROUP V PHOSPHOLIPASES A2; GROUP X PHOSPHOLIPASES A2; HUMANS; MUTATION; PHOSPHOLIPIDS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

ADENOVIRIDAE; APOIDEA; MAMMALIA;

EID: 36749018033     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbalip.2007.09.006     Document Type: Article

References (40)

1. 2s. Adv. Immunol. 77 (2001) 163-194
2. 2 enzymes. Prostaglandins Other Lipid Mediat 68-69 (2002) 3-58
3. 2s and cyclooxygenases in immediate and delayed prostanoid biosynthetic pathways. J. Biol. Chem. 274 (1999) 3103-3115
4. 2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J. Biol. Chem. 276 (2001) 10083-10096
5. 2 but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J. Biol. Chem. 275 (2000) 3179-3191
6. 2s in regulating arachidonic acid release and prostaglandin generation: implication of cyclooxygenase-2 induction and phospholipid scramblase-mediated cellular membrane perturbation. J. Biol. Chem. 274 (1999) 31435-31444
7. 2 with the glycosylphosphatidylinositol-anchored heparan sulfate proteoglycan in the cyclooxygenase-2-mediated delayed prostanoid biosynthetic pathway. J. Biol. Chem. 274 (1999) 29927-29936
8. 2 acts on the perinuclear membranes. J. Biol. Chem. 277 (2002) 9358-9365
9. 2a. J. Biol. Chem. 279 (2004) 25024-25038
10. 2. J. Clin. Invest. 97 (1996) 250-257
11. 2. J. Biol. Chem. 277 (2002) 5849-5857
12. 2 to Escherichia coli infection. Infect. Immun. 68 (2000) 87-92
13. 2. J. Immunol. 166 (2001) 4029-4034
14. 2 is required for parvovirus infectivity. Dev. Cell 1 (2001) 291-302
15. 2. J. Biol. Chem. 279 (2004) 14502-14508
16. 2s prevent adenovirus infection into mammalian cells. Biochem. J. 393 (2006) 97-106
17. 2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells. Biochem. J. 387 (2005) 27-38
18. 2 with homology to the group III bee venom enzyme. J. Biol. Chem. 275 (2000) 7492-7496
19. 2s (group III and XII). J. Biol. Chem. 278 (2003) 10657-10667
20. 2. J. Biol. Chem. 280 (2005) 24987-24998
21. 2, a new class of HIV inhibitors that block virus entry into host cells. J. Clin. Invest. 104 (1999) 611-618
22. 2 inhibits replication of T-cell tropic HIV-1 strains via interaction with the CXCR4 chemokine receptor. Mol. Pharmacol. 60 (2001) 341-347
23. Gunther-Ausborn S., Praetor A., and Stegmann T. Inhibition of influenza-induced membrane fusion by lysophosphatidylcholine. J. Biol. Chem. 270 (1995) 29279-29285
24. Gunther-Ausborn S., and Stegmann T. How lysophosphatidylcholine inhibits cell-cell fusion mediated by the envelope glycoprotein of human immunodeficiency virus. Virology 235 (1997) 201-208
25. 2-terminal SIV fusion peptide into the lipid bilayer. FEBS Lett. 333 (1993) 325-330
26. Vogel S.S., Leikina E.A., and Chernomordik L.V. Lysophosphatidylcholine reversibly arrests exocytosis and viral fusion at a stage between triggering and membrane merger. J. Biol. Chem. 268 (1993) 25764-25768
27. Yeagle P.L., Smith F.T., Young J.E., and Flanagan T.D. Inhibition of membrane fusion by lysophosphatidylcholine. Biochemistry 33 (1994) 1820-1827
28. Medina-Kauwe L.K. Endocytosis of adenovirus and adenovirus capsid proteins. Adv. Drug Deliv. Rev. 55 (2003) 1485-1496
29. Meier O., and Greber U.F. Adenovirus endocytosis. J. Gene Med. 6 (2004) S152-S163
30. Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine: G protein-coupled receptors and receptor-mediated signal transduction. Biochim. Biophys. Acta 1582 (2002) 81-88
31. 2s plays a critical role for neurite outgrowth induction in PC12 cells. Brain Res. 1015 (2004) 207-211
32. 2 induces vascular endothelial cell migration. Blood. 96 (2000) 3809-3815
33. 2. Blood 105 (2005) 3583-3587
34. 2 induces dendritic cell maturation. Eur. J. Immunol. 34 (2004) 2293-2302
35. Moreira L.A., Ito J., Ghosh A., Devenport M., Zieler H., Abraham E.G., Crisanti A., Nolan T., Catteruccia F., and Jacobs-Lorena M. Bee venom phospholipase inhibits Malaria parasite development in transgenic mosquitoes. J. Biol. Chem. 277 (2002) 40839-40843
36. 2 involved in N-type receptor binding and neurotoxicity. J. Biol. Chem. 272 (1997) 7173-7181
37. 2. Biochim. Biophys. Acta 1394 (1998) 57-64
38. 2 induced prominent release of arachidonic acid from human myeloid leukemia cells. J. Biol. Chem. 274 (1999) 34203-34211
39. 2 promotes neuronal outgrowth and survival. Biochem. J. (in press)
40. 2-mediated oleic acid mobilization in lipopolysaccharide-stimulated P388D1 macrophages. J. Biol. Chem. 275 (2000) 4783-4786